UPDATE 4-Glaxo boosted by drug comebacks, Q1 earnings

home   >   MSN news

market in the middle of this year after signing a legal agreement with regulators over a problem plant in Puerto Rico. ... on Thursday driven by strong sales of asthma drug Advair and Avandia for diabetes, extending early gains in the stock ...

- link to UPDATE 4-Glaxo boosted by drug comebacks, Q1 earnings -
Last update: 05/26/2005

Recommended Reading

    Advair Diskus throws GSK into the forefront: GlaxoSmithKline makes effective use of robotics to produce the No. 1 asthma inhaler.(Plants of the year: ... ine) : An article from: Food & Drug Packaging
    Advair Diskus throws GSK into the forefront: GlaxoSmithKline makes effective use of robotics to produce the No. 1 asthma inhaler.(Plants of the year: ... ine) : An article from: Food & Drug Packaging
    New and approved: Nasacort HFA Nasal Aerosol, Advair Diskus.(Rx) : An article from: Family Practice News
    Advair Diskus 250/50.(New & Approved) : An article from: Family Practice News
    FDA Panel Backs Combination Steroid-Bronchodilator Inhaler.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Controlando el asma.(Advair Diskus, inhalante)(TT: Treating asthma.)(TA: Advair Diskus inhalant)(Artculo Breve) : An article from: Semana
    FDA Panel Backs Combination Steroid-Bronchodilator Inhaler.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Advair Diskus.(New & Approved) : An article from: Pediatric News